Dr. Toney's career has spanned both the pharmaceutical industry and
academia. His academic training is in Chemistry (B.S., University of
Virginia; M.S. and Ph.D., Northwestern University) and included research
experience as a postdoctoral fellow in Molecular Biology (Dana Farber
Cancer Institute, Harvard Medical School) and in Chemical Biology (Massachusetts
Institute of Technology).
His
current scholarship is focused on drug discovery using an interdisciplinary
approach. As a Senior Research Fellow at Merck Research Laboratories,
he studied a variety of therapeutic targets for which high throughput
biochemical assays were developed. He has held the Herman and Margaret
Sokol Professorship in Chemistry at Montclair State University and served
as Department Chairperson of Chemistry and Biochemistry. During this
time, he developed a new graduate course, "Biomolecular Assay Development"
that emphasizes teaching of the drug development process, including
laboratory and in silico molecular modeling techniques. He is a member
of the Editorial Board of Assay and Drug Development Technologies and
is a Section Editor of Current Opinion in Investigational Drugs. He
has served seven times as a member of the review panel, "Assay
Development for High Throughput Molecular Screening" (R03, R21)
of the National Institutes of Health, Molecular Libraries and Imaging
Initiative. He has currently published 45 peer reviewed articles and
holds six U.S. patents. He is currently serving as Dean of the College
of Natural, Applied and Health Sciences at Kean University and is continuing
interdisciplinary research in drug discovery.